Clinical Trial Update: Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) [Phase 4]

View source ↗

Summary

Phase 4 real-world study evaluating outcomes of novel modulator therapy combinations in people with cystic fibrosis, including those with cystic fibrosis liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis Liver Disease

Snippet

Sponsor: Royal College of Surgeons, Ireland | Conditions: Cystic Fibrosis, Cystic Fibrosis Liver Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING